C
Chongqing Taiji Industry Group Co Ltd
SSE:600129
Chongqing Taiji Industry Group Co Ltd
SSE:600129
Price:
16.09
CNY
-4.17%
Market Closed
Market Cap:
¥8.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Chongqing Taiji Industry Group Co Ltd
SSE:600129
|
CN |
|
M
|
Makarony Polskie SA
WSE:MAK
|
PL |
|
Longhua Technology Group Luoyang Co Ltd
SZSE:300263
|
CN |
|
P
|
Prolintas Infra Business Trust
KLSE:PLINTAS
|
MY |
|
JW Life Science Corp
KRX:234080
|
KR |
|
Aap 101 Inc
OTC:AAPJ
|
JP |
|
Knights Group Holdings PLC
LSE:KGH
|
UK |
|
Nanjing Hicin Pharmaceutical Co Ltd
SZSE:300584
|
CN |
|
S
|
Spetz Inc
CNSX:SPTZ
|
CA |
|
V
|
Vikas Lifecare Ltd
NSE:VIKASLIFE
|
IN |
Relative Value
The Relative Value of one Chongqing Taiji Industry Group Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 16.09 CNY, Chongqing Taiji Industry Group Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Chongqing Taiji Industry Group Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Chongqing Taiji Industry Group Co Ltd Competitors
Chongqing Taiji Industry Group Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
C
|
Chongqing Taiji Industry Group Co Ltd
SSE:600129
|
8.9B CNY | 0.9 | -25.2 | 142.6 | 142.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
856.7B USD | 13.3 | 42.1 | 28.4 | 30.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.8B USD | 6 | 21.1 | 14.7 | 18 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 3.9 | 18.6 | 11.1 | 12.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.5B GBP | 4.9 | 28 | 15.6 | 21.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.4 | 15.6 | 9.7 | 11.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
221.8B CHF | 5.1 | 20.6 | 12.8 | 16.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD | 2.4 | 19.5 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.7B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
